SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-23-000064
Filing Date
2023-12-20
Accepted
2023-12-20 18:06:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2825
  Complete submission text file 0001974158-23-000064.txt   4264
Mailing Address 5871 OBERLIN DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Heyman Richard A. (Reporting) CIK: 0001584759 (see all company filings)

Type: 144

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Subject) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39247 | Film No.: 231502399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)